Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 9, 2019, after the close
10-Q filed May 9, 2019, 39 days after period end · 0000320017-19-000053
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | — | — | $7.92M | $7.49M |
| Net Income | -$4.37M | -$4.98M | -$9.79M | -$12.05M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.44 |
| -$0.52 |
| -$1.12 |
| -$2.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
